Chenying Guo is a seasoned professional in the field of translational sciences, currently serving as Senior Director at Flagship Pioneering and Pioneering Medicines. Previous roles include Associate Director of Retina Discovery at Johnson & Johnson Innovative Medicine and Director of Biomarker Research at Annexon Biosciences. Chenying's foundational experience was gained during a progression from Investigator I to III at Novartis Institutes for BioMedical Research (NIBR). Chenying holds a Ph.D. in Neurobiology and Neurophysiology from UCLA, obtained between 2004 and 2009.
June, 2024 - present